KAsH: A new tool to predict in-hospital mortality in patients with myocardial infarction

Joel Ponte Monteiro1, Ricardo Costa Rodrigues1, Micaela Neto1

  • 1Serviço de cardiologia, Hospital Dr. Nélio Mendonça, Funchal, Madeira, Portugal.

Insights

A new KAsH score for myocardial infarction (MI) patients offers superior in-hospital mortality prediction compared to existing methods. This simple clinical score aids early risk stratification for better patient outcomes.

Area of Science:

  • Cardiology
  • Clinical Risk Stratification
  • Myocardial Infarction Management

Background:

  • Complex risk scores have limitations in assessing myocardial infarction (MI) patient mortality.
  • There is a need for a simple, clinically applicable tool for early risk stratification of MI patients.

Purpose of the Study:

  • To develop and validate a simple clinical score, KAsH, for stratifying in-hospital mortality risk in MI patients.
  • To compare the predictive power of the KAsH score against existing validated scores.

Main Methods:

  • A single-center prospective registry of 1504 MI patients was analyzed.
  • Multivariate logistic regression identified key predictors of in-hospital mortality.
  • The KAsH score was calculated as (Killip class × Age × Heart rate) / systolic blood pressure.

Main Results:

  • The KAsH score demonstrated excellent predictive power (AUC 0.861), outperforming the GRACE score (AUC 0.773).
  • KAsH reclassified 81.5% of patients into better risk categories than the Killip classification.
  • Mortality discrimination was excellent across KAsH categories (1.0% to 55.2% mortality).

Conclusions:

  • The KAsH score is a simple, effective tool for predicting in-hospital mortality in MI patients at first medical contact.
  • KAsH offers superior predictive capacity compared to current risk scores and Killip classification.
  • This score facilitates early and accurate risk stratification, potentially improving patient management.
Abstract

Related Concept Videos

Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
505
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
711
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
155